Literature DB >> 15322102

Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate.

Elangovan Gopal1, You-Jun Fei, Mitsuru Sugawara, Seiji Miyauchi, Lina Zhuang, Pamela Martin, Sylvia B Smith, Puttur D Prasad, Vadivel Ganapathy.   

Abstract

We report here on the expression of slc5a8 in kidney and its relevance to Na(+)-coupled reabsorption of lactate. slc5a8 is the murine ortholog of SLC5A8, a candidate tumor suppressor gene, which we recently cloned from human intestine and demonstrated its functional identity as a Na(+)-coupled transporter for short-chain fatty acids and lactate. The slc5a8 cDNA, cloned from mouse kidney, codes for a protein consisting of 611 amino acids. When expressed heterologously in mammalian cells or Xenopus oocytes, slc5a8 mediates Na(+)-coupled electrogenic transport of lactate/pyruvate as well as short-chain fatty acids (e.g. acetate, propionate, and butyrate). The Na+/fatty acid stoichiometry varies depending on the fatty acid substrate (2:1 for lactate and 4:1 for propionate). This phenomenon of variable Na+/substrate stoichiometry depending on the fatty acid substrate is also demonstrable with human SLC5A8. In situ hybridization with sagittal sections of mouse kidney demonstrates abundant expression of the transcripts in the cortex as well as the medulla. Brush border membrane vesicles prepared from rabbit kidney are able to transport lactate in a Na(+)-coupled manner. The transport process exhibits the overshoot phenomenon, indicating uphill lactate transport in response to the transmembrane Na+ gradient. The Na(+)-coupled lactate transport in these membrane vesicles is inhibitable by short-chain fatty acids. We conclude that slc5a8 is expressed abundantly in the kidney and that it plays a role in the active reabsorption of lactate. slc5a8 is the first transporter known to be expressed in mammalian kidney that has the ability to mediate the Na(+)-coupled reabsorption of lactate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322102     DOI: 10.1074/jbc.M405365200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon.

Authors:  Sudha Ananth; Lina Zhuang; Elangovan Gopal; Shiro Itagaki; Babu Ellappan; Sylvia B Smith; Vadivel Ganapathy; Pamela Martin
Journal:  Biochem Biophys Res Commun       Date:  2010-02-21       Impact factor: 3.575

2.  Heterologous expression of Pharaonis halorhodopsin in Xenopus laevis oocytes and electrophysiological characterization of its light-driven Cl- pump activity.

Authors:  Akiteru Seki; Seiji Miyauchi; Saori Hayashi; Takashi Kikukawa; Megumi Kubo; Makoto Demura; Vadivel Ganapathy; Naoki Kamo
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

Review 3.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

4.  Establishing a definitive stoichiometry for the Na+/monocarboxylate cotransporter SMCT1.

Authors:  Michael J Coady; Bernadette Wallendorff; Francis Bourgeois; Francois Charron; Jean-Yves Lapointe
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

5.  Cellular expression of a monocarboxylate transporter (MCT1) in the mammary gland and sebaceous gland of mice.

Authors:  Kumiko Takebe; Junko Nio-Kobayashi; Hiromi Takahashi-Iwanaga; Takaji Yajima; Toshihiko Iwanaga
Journal:  Histochem Cell Biol       Date:  2008-12-02       Impact factor: 4.304

6.  Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.

Authors:  Muthusamy Thangaraju; Senthil K Karunakaran; Shiro Itagaki; Elangovan Gopal; Selvakumar Elangovan; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

7.  Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2).

Authors:  Sonne R Srinivas; Elangovan Gopal; Lina Zhuang; Shirou Itagaki; Pamela M Martin; You-Jun Fei; Vadivel Ganapathy; Puttur D Prasad
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

8.  A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.

Authors:  Nisha Vijay; Bridget L Morse; Marilyn E Morris
Journal:  Pharm Res       Date:  2014-12-06       Impact factor: 4.200

9.  Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer.

Authors:  Muthusamy Thangaraju; Gail Cresci; Shiro Itagaki; John Mellinger; Darren D Browning; Franklin G Berger; Puttur D Prasad; Vadivel Ganapathy
Journal:  J Gastrointest Surg       Date:  2008-07-26       Impact factor: 3.452

10.  Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice.

Authors:  Henning Frank; Nicole Gröger; Martin Diener; Christoph Becker; Thomas Braun; Thomas Boettger
Journal:  J Biol Chem       Date:  2008-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.